Detalles de la búsqueda
1.
A phase 1b study of trebananib in combination with pegylated liposomal doxorubicin or topotecan in women with recurrent platinum-resistant or partially platinum-sensitive ovarian cancer.
Gynecol Oncol
; 135(1): 25-33, 2014 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-25019569
2.
Performance characteristics of a polymerase chain reaction-based assay for the detection of EGFR mutations in plasma cell-free DNA from patients with non-small cell lung cancer using cell-free DNA collection tubes.
PLoS One
; 19(4): e0295987, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38593164
3.
Efficacy of liquid biopsy for disease monitoring and early prediction of tumor progression in EGFR mutation-positive non-small cell lung cancer.
PLoS One
; 17(4): e0267362, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35482671
4.
Budget Impact Analysis of EGFR Mutation Liquid Biopsy for First- and Second-Line Treatment of Metastatic Non-Small Cell Lung Cancer in Greece.
Diagnostics (Basel)
; 10(6)2020 Jun 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-32599934
5.
Polymorphisms and clinical outcome in recurrent ovarian cancer treated with cyclophosphamide and bevacizumab.
Clin Cancer Res
; 14(22): 7554-63, 2008 Nov 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-19010874
6.
Clinical utility of a blood-based EGFR mutation test in patients receiving first-line erlotinib therapy in the ENSURE, FASTACT-2, and ASPIRATION studies.
Lung Cancer
; 126: 1-8, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30527172
7.
Detection of EGFR Variants in Plasma: A Multilaboratory Comparison of a Real-Time PCR EGFR Mutation Test in Europe.
J Mol Diagn
; 20(4): 483-494, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29704571
8.
The Clinical and Economic Impact of Inaccurate EGFR Mutation Tests in the Treatment of Metastatic Non-Small Cell Lung Cancer.
J Pers Med
; 7(3)2017 Jun 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-28657610
9.
Long-term results of maximally aggressive trimodality therapy in a high-risk subset of early-stage cervical cancer patients.
J Reprod Med
; 51(5): 383-8, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16779984
10.
Phase II trial of carboplatin and infusional cyclosporine in platinum-resistant recurrent ovarian cancer.
Cancer Chemother Pharmacol
; 54(4): 283-9, 2004 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-15184995
11.
Intermittent erlotinib in combination with pemetrexed: phase I schedules designed to achieve pharmacodynamic separation.
J Thorac Oncol
; 4(7): 862-8, 2009 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-19494788
12.
Phase II clinical trial of bevacizumab and low-dose metronomic oral cyclophosphamide in recurrent ovarian cancer: a trial of the California, Chicago, and Princess Margaret Hospital phase II consortia.
J Clin Oncol
; 26(1): 76-82, 2008 Jan 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18165643
13.
Low-dose warfarin does not decrease the rate of thrombosis in patients with cervix and vulvo-vaginal cancer treated with chemotherapy, radiation, and erythropoeitin.
Gynecol Oncol
; 102(1): 98-102, 2006 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-16406065
14.
Paclitaxel and carboplatin with amifostine in advanced, recurrent, or refractory endometrial adenocarcinoma: a phase II study of the Southwest Oncology Group.
Gynecol Oncol
; 96(3): 610-5, 2005 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15721401
15.
Increased incidence of symptomatic venous thrombosis in patients with cervical carcinoma treated with concurrent chemotherapy, radiation, and erythropoietin.
Cancer
; 98(7): 1514-20, 2003 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-14508840
16.
Randomized Phase II trial of two high-dose chemotherapy regimens with stem cell transplantation for the treatment of advanced ovarian cancer in first remission or chemosensitive relapse: a Southwest Oncology Group study.
Gynecol Oncol
; 94(1): 98-106, 2004 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-15262126
17.
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.
Cancer J
; 10(5): 294-300, 2004.
Artículo
en Inglés
| MEDLINE | ID: mdl-15530258
Resultados
1 -
17
de 17
1
Próxima >
>>